Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMicrosaic Regulatory News (MSYS)

  • There is currently no data for MSYS

Trading Statement

24 Feb 2016 07:00

RNS Number : 9368P
Microsaic Systems plc
24 February 2016
Ā 

Microsaic Systems plc

Ā 

("Microsaic", "Microsaic Systems" or the "Company")Ā 

Update on Operations and Notice of Results

Ā 

24 February 2016

Ā 

Microsaic Systems plc (AIM: MSYS), the developer of miniaturised chip-based scientific instruments, announces an improved business performance in the six months to 31 December 2015. The Company sold seventeen 4000 MiDĀ® units in H2 2015 versus six units in H1 2015. The Board anticipates that sales for H1 2016 will continue this positive trend. The Company is pleased to announce that it has also signed a new distributor agreement for the 4000 MiDĀ®; details of which will be provided in the 2015 Annual Report.

Ā 

The Company also announces that following a strategic review of the route-to-market for its advanced "triple quad" technology, the Company's development agreement announced on 25 September 2014 with an OEM partner has been terminated. The Company aims to finalise the development of its first triple quad prototype in the middle of 2016 and begin preliminary testing for defined applications. These actions will enable the Company to pursue a strategy of multiple outlets into each application area and hence reduce its dependency on any one international market participant.

Ā 

Furthermore, the Company has identified a number of innovative new application areas for its current "single quad" products and early stage contacts are being made with appropriate companies to be partners for these. As a result, further OEM contracts are expected through 2016 and 2017. The Company has completed a review of its sales and marketing strategy, training and client literature - the results of which are in the process of being implemented.

Ā 

The Company will announce its preliminary results for the year ended 31 December 2015 around 16 March 2016.

Ā 

Enquiries:

Ā 

Microsaic Systems plc

via Citigate Dewe Rogerson

Colin Nicholl, Chairman

Ā 

Jim Ramage, CEO

Ā 

Ā 

Ā 

Numis Securities Limited

+44 (0)20 7260 1000

Stuart Skinner (Nominated Adviser)

James Serjeant (Broker)

Ā 

Ā 

Ā 

Citigate Dewe Rogerson (Financial PR)

+44 (0)20 7282 2948/1068

Mark Swallow, Marine Perrier

Ā 

Ā 

About Microsaic Systems

Ā 

Microsaic Systems plc is a high technology company developing and marketing next generation mass spectrometry (MS) instruments for the analysis of gaseous, liquid and solid samples. Microsaic has successfully miniaturised mass spectrometry into a desktop instrument by integrating the key MS components onto patented chip technologies (called ionchipĀ®, spraychipĀ® and vac-chipā„¢). Microsaic's MS products retain the functionality of larger, conventional MS systems but are substantially smaller, lighter, consume less energy and have lower running costs. The Microsaic 4000 MiDĀ® is the world's smallest MS system.

Ā 

Mass spectrometry is a 'gold-standard' analytical technique used across many industry sectors, including pharmaceutical, diagnostics and healthcare, government, energy, utilities, environmental, food and drink, security and defence, and industrial chemicals - a combined market estimated to grow to $2.5 billion by 2017. Microsaic aims to introduce compact, deployable MS products, based on its core technology, into a series of these target markets.

Ā 

Microsaic Systems was established in 2001 by a team including founders from Imperial College London, and was admitted to AIM in April 2011 under the symbol MSYS. www.microsaic.comĀ 

This information is provided by RNS
The company news service from the London Stock Exchange
Ā 
END
Ā 
Ā 
TSTLFFIFFRIVFIR
Date   Source Headline
19th Jun 20177:00 amRNSTrading Statement
15th May 201711:42 amRNSResult of AGM
11th May 20177:00 amRNSMicrosaic Enhances Bioprocessing Capabilities
26th Apr 20177:00 amRNSIntegration with SCPA chromatography software
21st Apr 20177:00 amRNSNotice of AGM
7th Apr 20177:00 amRNSAgreement
21st Mar 20177:00 amRNSFinal Results
13th Mar 20177:00 amRNSChange of registrar
24th Jan 201712:56 pmRNSAppointment of Interim Chairman
13th Dec 20167:00 amRNSTrading Statement
28th Sep 20167:00 amRNSDirectorate Change
21st Sep 20164:39 pmRNSHolding(s) in Company
16th Sep 20161:44 pmRNSDirector/PDMR Shareholding
15th Sep 20161:03 pmRNSHolding(s) in Company
15th Sep 201610:02 amRNSTR-1: Notification of Major Interest in Shares
14th Sep 20165:23 pmRNSHolding(s) in Company
14th Sep 20163:38 pmRNSGrant of Options
13th Sep 20164:46 pmRNSHolding(s) in Company
13th Sep 201610:45 amRNSHolding(s) in Company
13th Sep 20168:40 amRNSHolding(s) in Company
13th Sep 20168:30 amRNSDirector/PDMR Shareholding
12th Sep 201611:53 amRNSResult of GM, Completion of Placing, TVRs
26th Aug 20164:49 pmRNSResult of Placing
26th Aug 20161:15 pmRNSHalf-year Report
26th Aug 20161:15 pmRNSProposed Placing of New Shares
20th Jun 20163:27 pmRNSAGM Statement
13th Jun 20167:00 amRNSChange of Nominated Adviser and Broker
19th May 20167:00 amRNSDistribution of Annual Report and Accounts
13th May 201612:57 pmRNSAGM Change of Date
16th Mar 20167:00 amRNSAnnual Financial Report
8th Mar 20167:00 amRNSDirectorate Change
24th Feb 20167:00 amRNSTrading Statement
14th Jan 20167:00 amRNSAward of Options
21st Dec 20157:00 amRNSDirectorate Change
2nd Dec 20157:04 amRNSTrading Update & Directorate Change
30th Nov 201511:47 amRNSHolding(s) in Company
23rd Oct 201511:41 amRNSHolding(s) in Company
22nd Oct 20151:12 pmRNSHolding(s) in Company
19th Oct 20151:37 pmRNSResults of EGM and Placing
15th Oct 20157:00 amRNSPlacing - Exercise of Additional Demand Option
13th Oct 20153:30 pmRNSDirector/PDMR Shareholding
30th Sep 20157:44 amRNSPlacing of New Shares
30th Sep 20157:00 amRNSInterim Results
20th May 20157:00 amRNSResult of AGM
8th Apr 20158:34 amRNSNotification of Major Interest in Shares
30th Mar 20157:00 amRNSDistribution of Annual Report and Accounts
23rd Mar 20157:00 amRNSAnnual Financial Report
19th Mar 20157:00 amRNSAppoinment of Chief Operating Officer
16th Mar 20157:00 amRNSOEM Supply Agreement with GE Healthcare
6th Jan 20158:40 amRNSExercise of Share Options

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.